Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garnick

Showing results (291-300 of 305) with videos related to

Pageof 31
Sort By:
Journal of Substance Abuse Treatment|January 25, 2011
Lessons from five states: public sector use of the Washington Circle performance measuresDeborah W Garnick, Margaret T Lee, Constance Horgan, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1996
Novel assays based on human growth hormone receptor as alternatives to the rat weight gain bioassay for recombinant human growth hormoneE C Roswall, V R Mukku, A B Chen, et al.
The Canadian Journal of Urology|April 20, 2024
Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathwaysDavid E Crawford, David Albala, Marc B Garnick, et al.
Journal of Studies on Alcohol and Drugs|December 9, 2014
Performance measures and racial/ethnic disparities in the treatment of substance use disordersAndrea Acevedo, Deborah W Garnick, Robert Dunigan, et al.
Protein Expression and Purification|March 23, 2010
High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applicationsShelly A Pizarro, Jane Gunson, Matthew J Field, et al.
The American Journal of Medicine|March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activityE Frei, R H Blum, S W Pitman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanomaA A Jakubowski, D F Bajorin, M A Templeton, et al.
Blood|May 1, 1996
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapyI Tepler, L Elias, J W Smith, et al.
Journal of Substance Abuse Treatment|November 19, 2013
Criminal justice outcomes after engagement in outpatient substance abuse treatmentDeborah W Garnick, Constance M Horgan, Andrea Acevedo, et al.
Journal of Substance Abuse Treatment|June 11, 2014
A performance measure for continuity of care after detoxification: relationship with outcomesMargaret T Lee, Constance M Horgan, Deborah W Garnick, et al.
Pageof 31

Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Journal of Substance Abuse Treatment|January 25, 2011
Lessons from five states: public sector use of the Washington Circle performance measuresDeborah W Garnick, Margaret T Lee, Constance Horgan, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1996
Novel assays based on human growth hormone receptor as alternatives to the rat weight gain bioassay for recombinant human growth hormoneE C Roswall, V R Mukku, A B Chen, et al.
The Canadian Journal of Urology|April 20, 2024
Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathwaysDavid E Crawford, David Albala, Marc B Garnick, et al.
Journal of Studies on Alcohol and Drugs|December 9, 2014
Performance measures and racial/ethnic disparities in the treatment of substance use disordersAndrea Acevedo, Deborah W Garnick, Robert Dunigan, et al.
Protein Expression and Purification|March 23, 2010
High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applicationsShelly A Pizarro, Jane Gunson, Matthew J Field, et al.
The American Journal of Medicine|March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activityE Frei, R H Blum, S W Pitman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanomaA A Jakubowski, D F Bajorin, M A Templeton, et al.
Blood|May 1, 1996
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapyI Tepler, L Elias, J W Smith, et al.
Journal of Substance Abuse Treatment|November 19, 2013
Criminal justice outcomes after engagement in outpatient substance abuse treatmentDeborah W Garnick, Constance M Horgan, Andrea Acevedo, et al.
Journal of Substance Abuse Treatment|June 11, 2014
A performance measure for continuity of care after detoxification: relationship with outcomesMargaret T Lee, Constance M Horgan, Deborah W Garnick, et al.
Pageof 31